Literature DB >> 15054563

Recombinant t-PA in myocardial ischemia after switch operation.

A Tzifa1, U Joashi, Z Slavik.   

Abstract

A well-recognized complication of the anatomic correction (arterial switch operation) of transposition of the great arteries is obstruction of the translocated coronary arteries. Myocardial reperfusion has previously been achieved by surgical revascularization or percutaneous balloon angioplasty. We report the case of a 3-month-old infant who suffered myocardial infarction 11 weeks after the arterial switch operation, in whom myocardial reperfusion was established following infusion of recombinant tissue-type plasminogen activator (Alteplase).

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15054563     DOI： 10.1007/s00246-003-0473-8

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN： 0172-0643            Impact factor:   1.655


  10 in total

1.  Results of the arterial switch operation in neonates with transposed great arteries.

Authors:  R Prêtre; D Tamisier; P Bonhoeffer; P Mauriat; P Pouard; D Sidi; P Vouhé
Journal:  Lancet       Date:  2001-06-09       Impact factor: 79.321

Review 2.  Coronary arterial complications before and after the arterial switch operation: is the future clear?

Authors:  Aphrodite Tzifa; Robert M R Tulloh
Journal:  Cardiol Young       Date:  2002-03       Impact factor: 1.093

3.  Successful treatment of neonatal aortic thrombosis with tissue plasminogen activator.

Authors:  L A Kennedy; W H Drummond; M E Knight; M M Millsaps; J L Williams
Journal:  J Pediatr       Date:  1990-05       Impact factor: 4.406

4.  Percutaneous transluminal coronary angioplasty in an infant with coronary artery stenosis after arterial switch operation.

Authors:  V Allada; J M Jarmakani; L Yeatman
Journal:  Am Heart J       Date:  1991-11       Impact factor: 4.749

5.  Coronary angioplasty for coronary stenosis after the arterial switch procedure.

Authors:  G Hausdorf; C Kampmann; M Schneider
Journal:  Am J Cardiol       Date:  1995-09-15       Impact factor: 2.778

6.  Tissue plasminogen activator for the treatment of thromboembolism in infants and children.

Authors:  M Levy; L N Benson; P E Burrows; Y Bentur; D K Strong; J Smith; D Johnson; S Jacobson; G Koren
Journal:  J Pediatr       Date:  1991-03       Impact factor: 4.406

7.  The influence of coronary anatomy on the arterial switch operation in neonates.

Authors:  R W Day; H Laks; D C Drinkwater
Journal:  J Thorac Cardiovasc Surg       Date:  1992-09       Impact factor: 5.209

8.  Significance of arrhythmias during the first 24 hours of acute myocardial infarction treated with alteplase and effect of early administration of a beta-blocker or a bradycardiac agent on their incidence.

Authors:  H Heidbüchel; J Tack; L Vanneste; A Ballet; H Ector; F Van de Werf
Journal:  Circulation       Date:  1994-03       Impact factor: 29.690

9.  Recombinant tissue-type plasminogen activator therapy of thrombosis in 16 neonates.

Authors:  C Farnoux; O Camard; D Pinquier; M F Hurtaud-Roux; G Sebag; N Schlegel; F Beaufils
Journal:  J Pediatr       Date:  1998-07       Impact factor: 4.406

Review 10.  Recommendations for tPA thrombolysis in children. On behalf of the Scientific Subcommittee on Perinatal and Pediatric Thrombosis of the Scientific and Standardization Committee of the International Society of Thrombosis and Haemostasis.

Authors:  Marilyn J Manco-Johnson; E F Grabowski; M Hellgreen; A S Kemahli; M P Massicotte; W Muntean; M Peters; N Schlegel; M Wang; U Nowak-Göttl
Journal:  Thromb Haemost       Date:  2002-07       Impact factor: 5.249
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.